BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38677747)

  • 1. Prognostic Significance of NQO1 Expression in Non-neoplastic Esophageal Squamous Epithelium for Patients With Esophageal Cancer.
    Ichikawa H; Ishikawa T; Sugai M; Muneoka Y; Kano Y; Ueki H; Abe S; Moro K; Hirose Y; Miura K; Shimada Y; Sakata J; Wakai T
    Anticancer Res; 2024 May; 44(5):1915-1924. PubMed ID: 38677747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran.
    Marjani HA; Biramijamal F; Rakhshani N; Hossein-Nezhad A; Malekzadeh R
    Genet Mol Res; 2010 Feb; 9(1):239-49. PubMed ID: 20198579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy.
    Zhang F; Zhu X; Zhang Q; Zhou P; Hao L
    Aging (Albany NY); 2021 Jul; 13(14):18827-18838. PubMed ID: 34297698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
    Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
    Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of change in the Naples prognostic score after neoadjuvant chemoradiotherapy on survival in esophageal squamous cell carcinoma patients.
    Zhang H; Xiao X; Luan S; Li X; Sun S; Yuan Y
    Saudi Med J; 2024 May; 45(5):481-489. PubMed ID: 38734428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
    Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
    Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma.
    Zhao Y; Chen D; Wang W; Zhao T; Wen J; Zhang F; Duan S; Chen C; Sang Y; Zhang Y; Chen Y
    Ann Thorac Surg; 2020 May; 109(5):1551-1557. PubMed ID: 31987829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
    Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
    Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
    Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
    Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
    Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
    Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
    Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
    Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
    Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
    Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.
    Mizumoto A; Ohashi S; Kamada M; Saito T; Nakai Y; Baba K; Hirohashi K; Mitani Y; Kikuchi O; Matsubara J; Yamada A; Takahashi T; Lee H; Okuno Y; Kanai M; Muto M
    J Gastroenterol; 2019 Aug; 54(8):687-698. PubMed ID: 30737573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
    Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
    Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.